Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. (Q44675295)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

title

Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

Merlin Thomas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

author name string

B J Davis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

G Jerums

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

W C Burns

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

H Kawachi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

T J Allen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

M E Cooper

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

publication date

29 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

89-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14647892 AND SRC:MED&resulttype=core&format=json

Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products

21 December 2019

cites work

1 reference

12 December 2020

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment

1 reference

12 December 2020

Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility

1 reference

12 December 2020

Renoprotective effects of a novel inhibitor of advanced glycation

1 reference

12 December 2020

Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy

1 reference

12 December 2020

Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.

1 reference

12 December 2020

Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.

1 reference

12 December 2020

Angiotensin II as a renal growth factor

1 reference

12 December 2020

Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics

1 reference

12 December 2020

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

1 reference

12 December 2020

A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)

1 reference

12 December 2020

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

1 reference

12 December 2020

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy

1 reference

12 December 2020

Blockade of the renin-angiotensin and endothelin systems on progressive renal injury

1 reference

12 December 2020

Lilly Lecture 1993. Glycation and diabetic complications

1 reference

12 December 2020

Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding

1 reference

12 December 2020

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

1 reference

12 December 2020

Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring

1 reference

12 December 2020

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

1 reference

12 December 2020

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

12 December 2020

Nephrin is specifically located at the slit diaphragm of glomerular podocytes

1 reference

12 December 2020

Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat

1 reference

12 December 2020

Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis

1 reference

12 December 2020

Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes

1 reference

12 December 2020

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

1 reference

12 December 2020

Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats

1 reference

12 December 2020

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group

1 reference

12 December 2020

Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin

1 reference

12 December 2020

Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system.

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

Pathogenesis, prevention, and treatment of diabetic nephropathy

1 reference

12 December 2020

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

1 reference

12 December 2020

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

1 reference

12 December 2020

Angiotensin receptor blockers -- finally the evidence is coming in: IDNT and RENAAL.

1 reference

12 December 2020

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

1 reference

12 December 2020

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

12 December 2020

Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine

1 reference

12 December 2020

Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy

1 reference

12 December 2020

Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states

1 reference

12 December 2020

The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

1 reference

12 December 2020

Nephrin in experimental glomerular disease.

1 reference

12 December 2020

Role of transforming growth factor-beta in diabetic glomerulosclerosis and renal hypertrophy.

1 reference

12 December 2020

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

1 reference

12 December 2020

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

12 December 2020

Validation in awake rats of a tail-cuff method for measuring systolic pressure

1 reference

12 December 2020

The enhancement of aminonucleoside nephrosis by the co-administration of protamine

1 reference

12 December 2020

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

1 reference

12 December 2020

Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms

1 reference

12 December 2020

Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition

1 reference

12 December 2020

ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

1 reference

12 December 2020

Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020